Avoro Capital Advisors LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 189 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$92,660,000
+90.0%
2,000,0000.0%3.20%
+51.9%
Q1 2019$48,760,000
+55.4%
2,000,000
+4.0%
2.11%
+40.7%
Q1 2018$31,378,000
-55.3%
1,922,655
-65.3%
1.50%
-67.1%
Q4 2017$70,207,000
+4.3%
5,543,029
-5.3%
4.55%
-12.9%
Q3 2017$67,342,000
+89.5%
5,853,029
+25.2%
5.22%
+16.4%
Q2 2017$35,535,000
+4.0%
4,675,376
+0.7%
4.49%
+2.7%
Q1 2017$34,183,000
+2331.2%
4,641,400
+2800.9%
4.37%
+1437.7%
Q4 2016$1,406,000160,0000.28%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders